168 related articles for article (PubMed ID: 33015769)
21. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.
Liu HZ; Liu GY; Pang WW; Zhang H; Zeng ZJ; Wang HJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1682-1687. PubMed ID: 32141534
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer.
Yang XS; Wang GX; Luo L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):616-622. PubMed ID: 29461589
[TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNA Small Nucleolar RNA Host Gene 17 Promotes Hepatocellular Carcinoma Progression by Inhibiting p57 Expression.
Peng X; Zou R; Pan C; Li D
Ann Clin Lab Sci; 2021 Nov; 51(6):766-771. PubMed ID: 34921029
[TBL] [Abstract][Full Text] [Related]
24. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract][Full Text] [Related]
25. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
Yao N; Yu L; Zhu B; Gan HY; Guo BQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
[TBL] [Abstract][Full Text] [Related]
26. LncRNA SNHG17 predicts poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma.
Zhu XM; Li L; Ren LL; Du L; Wang YM
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4219-4227. PubMed ID: 34227089
[TBL] [Abstract][Full Text] [Related]
27. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
28. DUXAP8 promotes the proliferation and migration of ovarian cancer cells via down-regulating microRNA-29a-3p expression.
Li LM; Hao SJ; Ni M; Jin S; Tian YQ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1837-1844. PubMed ID: 33660793
[TBL] [Abstract][Full Text] [Related]
29. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
30. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
31. [Effects of Targeting lncRNA
Zhou YF; Chen DY; Chu YF; Zheng QW; Xu ZB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):352-357. PubMed ID: 30014633
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
33. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
[TBL] [Abstract][Full Text] [Related]
34. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
37. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
39. Highly expressed long non-coding RNA DUXAP10 promotes proliferation of ovarian cancer.
Zhang Q; Wang WW; Xu TH; Xu ZF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):314-321. PubMed ID: 29424918
[TBL] [Abstract][Full Text] [Related]
40. lncRNA SNHG17 promotes pancreatic carcinoma progression via cross-talking with miR-942.
Zhao L; Ye J; Lu Y; Sun C; Deng X
Am J Transl Res; 2021; 13(3):1037-1050. PubMed ID: 33841638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]